SCHEMBL19339697

SCHEMBL19339697

Cc1cc(NP)ccc1-c1ccc(NP)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
CYP17A1 P05093 3/20 0.36
ALDH1A1 P00352 2/20 0.35
ALOX15 P16050 2/20 0.35
CYP3A4 P08684 1/20 0.35
THRB P10828 1/20 0.35
RECQL P46063 1/20 0.35
HIF1A Q16665 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
G6PD P11413 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.33
MET P08581 1/20 0.33
APP P05067 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19339696 0.88 ALDH1A1 (0.45) KDM4EALDH1A1ALOX15CYP3A4THRB
SCHEMBL15317985 0.77 KDM4E (0.44) KDM4ECYP17A1ALDH1A1ALOX15CYP3A4
SCHEMBL19339699 0.76 CYP1A2 (0.49) KDM4EALDH1A1CYP3A4TDP1MEN1
SCHEMBL9717234 0.75 KDM4E (0.43) KDM4ECYP17A1ALDH1A1ALOX15CYP3A4
SCHEMBL4639004 0.75 HPGD (0.58) KDM4EALDH1A1ALOX15CYP3A4THRB
SCHEMBL20872048 0.75 PLA2G7 (0.50) KDM4EALDH1A1ALOX15CYP3A4THRB
SCHEMBL29416259 0.75 HPGD (0.58) KDM4EALDH1A1ALOX15CYP3A4THRB
SCHEMBL13308526 0.75 HPGD (0.58) KDM4EALDH1A1ALOX15CYP3A4THRB
SCHEMBL10755679 0.72 NPSR1 (0.64) ALDH1A1CYP3A4MEN1GAAKMT2A
SCHEMBL23567608 0.70 HPGD (0.52) KDM4EALDH1A1ALOX15CYP3A4THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3309157-B1 ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2019-09-04 EP disclosed
EP-3309157-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2018-04-18 EP disclosed
EP-3002281-B1 ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2017-09-13 EP disclosed